MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
789.28%
Quick Ratio
773.18%
Cash Ratio
110.91%
Debt to Asset Ratio
85.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Other current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible senior notes, net-Co...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
350,065
173,381
338,341
297,304
Short-term investments
1,704,520
1,745,732
1,901,830
1,992,676
Escrow deposit for maturity of 0 percent convertible senior notes due april 2026
-
632,511
-
-
Contracts receivable
58,845
73,684
24,608
52,580
Inventories
50,833
5,557
10,470
8,481
Other current assets
327,011
306,080
243,744
226,109
Total current assets
2,491,274
2,936,945
2,518,993
2,577,150
Property, plant and equipment, net
155,131
142,401
106,117
111,951
Right-of-use assets
231,560
235,064
241,993
163,933
Deposits and other assets
116,536
135,559
165,988
132,099
Total assets
2,994,501
3,449,969
3,033,091
2,985,133
Accounts payable
47,704
26,030
14,326
22,800
Accrued compensation
50,293
36,049
57,019
46,564
Accrued liabilities
115,778
126,549
99,310
98,957
Income taxes payable
2,877
2,874
101
81
0 percent convertible senior notes due april 2026, net
0
432,500
630,911
630,118
Current portion of deferred contract revenue
73,837
69,199
76,986
75,910
Convertible senior notes, net-Convertible Senior Notes175Percent
-
-
567,123
566,420
Other current liabilities
25,149
23,390
24,803
22,806
Convertible senior notes, net-Convertible Senior Notes0Percent
-
-
0
0
Total current liabilities
315,638
716,591
903,456
897,236
Long-term deferred contract revenue
63,030
75,745
107,906
125,095
Convertible senior notes, net-Convertible Senior Notes Due2030
753,356
752,425
-
-
Convertible senior notes, net-Convertible Senior Notes Due2028
569,255
568,540
-
-
Liability related to sale of future royalties, net
562,574
557,765
545,182
541,205
Long-term lease liabilities
262,476
259,215
262,672
164,379
Long-term obligations
28,435
28,274
28,785
59,074
Total liabilities
2,554,764
2,958,555
2,415,124
2,353,409
Common stock, 0.001 par value 300,000,000 shares authorized, 165,636,792 and 163,304,875 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
166
166
161
159
Additional paid-in capital
3,311,837
3,245,994
3,045,585
2,932,747
Accumulated other comprehensive loss
-33,897
-31,023
-25,978
-27,987
Accumulated deficit
-2,838,369
-2,723,723
-2,401,801
-2,273,195
Total stockholders' equity
439,737
491,414
617,967
631,724
Total liabilities and stockholders equity
2,994,501
3,449,969
3,033,091
2,985,133
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$1,704,520K (-14.46%↓ Y/Y)Cash and cashequivalents$350,065K (17.75%↑ Y/Y)Other current assets$327,011K (44.63%↑ Y/Y)Contracts receivable$58,845K (11.92%↑ Y/Y)Inventories$50,833K (499.38%↑ Y/Y)Total current assets$2,491,274K (-3.33%↓ Y/Y)Right-of-use assets$231,560K (41.25%↑ Y/Y)Property, plant andequipment, net$155,131K (38.57%↑ Y/Y)Deposits and other assets$116,536K (-11.78%↓ Y/Y)Total assets$2,994,501K (0.31%↑ Y/Y)Total liabilities andstockholders equity$2,994,501K (0.31%↑ Y/Y)Total liabilities$2,554,764K (8.56%↑ Y/Y)Total stockholders'equity$439,737K (-30.39%↓ Y/Y)Accumulated deficit-$2,838,369K (-24.86%↓ Y/Y)Accumulated othercomprehensive loss-$33,897K (-21.12%↓ Y/Y)Convertible senior notes,net-Convertible Senior Notes...$753,356K Convertible senior notes,net-Convertible Senior Notes...$569,255K Liability related to saleof future...$562,574K (3.95%↑ Y/Y)Total currentliabilities$315,638K (-64.82%↓ Y/Y)Long-term leaseliabilities$262,476K (59.68%↑ Y/Y)Long-term deferredcontract revenue$63,030K (-49.61%↓ Y/Y)Long-term obligations$28,435K (-51.87%↓ Y/Y)Additional paid-in capital$3,311,837K (12.93%↑ Y/Y)Common stock, 0.001 parvalue 300,000,000...$166K (4.40%↑ Y/Y)Accrued liabilities$115,778K (17.00%↑ Y/Y)Current portion ofdeferred contract...$73,837K (-2.73%↓ Y/Y)Accrued compensation$50,293K (8.01%↑ Y/Y)Accounts payable$47,704K (109.23%↑ Y/Y)Other currentliabilities$25,149K (10.27%↑ Y/Y)Income taxes payable$2,877K (3451.85%↑ Y/Y)

IONIS PHARMACEUTICALS INC (IONS)

IONIS PHARMACEUTICALS INC (IONS)